510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K022317Substantially Equivalent

Dana Diabecare II Insulin Pump & Superline-Easyrelease, Soft-Release-St, & Soft-Release-R Infusion Sets

Sooil Development Co., Ltd., North Attleboro MA / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K022317 is the FDA 510(k) clearance record for DANA DIABECARE II INSULIN PUMP & SUPERLINE-EASYRELEASE, SOFT-RELEASE-ST, & SOFT-RELEASE-R INFUSION SETS, a class II device, cleared for Sooil Development Co., Ltd. on under FDA product code LZG (Pump, Infusion, Insulin). FDA records list 4 510(k) clearances for Sooil Development Co., Ltd., from to . As of , FDA records show no recalls naming K022317.

Clearance record

Decision date
Received
(16 days to decision)
Product code
LZG Pump, Infusion, Insulin
Regulation
21 CFR 880.5725
Device class
Class II
Review panel
General Hospital
Applicant
Sooil Development Co., Ltd. 49 Plain St., North Attleboro MA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LZG

Trailing 12 months
2 clearances under product code LZG in the twelve months to October 2026, April 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code LZG, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20261
May 20260
June 20260
July 20260
August 20260
September 20261
October 20260